Top Markets
Coin of the day
Össur hf. Össur hf.

Össur hf.

OSSR
주식 순위 #7164
Össur hf. and its subsidiaries are actively involved in the creation,... Össur hf. and its subsidiaries are actively involved in the creation, advancement, manufacturing, and global distribution of non-invasive orthopedic medical devices. Their reach extends across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's operations are divided into two main business units: Prosthetics and Bracing & Supports. The Prosthetics division supplies both mechanical devices, such as lower limb and finger prostheses, and cutting-edge bionic products. These bionic solutions, designed for amputees, incorporate microprocessor-controlled feet, knees, hands, liners, and other integrated components featuring sensors, computing power, intrinsic intelligence, and actuators. In contrast, the Bracing & Supports segment offers a variety of supportive equipment for areas like the spine, knees, hips, feet, ankles, and hands. These products serve both therapeutic and preventative purposes by stabilizing joints and other body parts, in addition to providing injury management solutions to aid the healing of fractures and ligament injuries. Össur's primary customer base consists of specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgical centers. The company distributes its offerings through a combination of its own direct sales force and a network of third-party distributors. Founded in 1971 and headquartered in Reykjavik, Iceland, Össur hf. operates as a subsidiary of William Demant Invest A/S.
주가
$4.26
마지막 동기화: 2024-05-03
시가총액
$1.70B
변동 (1일)
0.99%
변동 (1년)
0.00%
국가
IS
거래 Össur hf. (OSSR)

카테고리

Össur hf. (OSSR)의 수익
2026 기준 수익 TTM: 0
Össur hf.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Össur hf.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
- -
DE